Table 2.
Clinical Variables according to Outcome
| Variable | ILAE I | ILAE II–VI | χ2/F; p |
|---|---|---|---|
| No. | 47 (54%) | 40 (46%) | — |
| F/M | 21/26 | 26/14 | χ2 = 2.82; 0.10 |
| Age at MRI, yr [SD] | 39.4 [12.6] | 39.5 [14.3] | F = 0.002; 0.97 |
| Age at onset of mTLE, yr [SD] | 16.8 [11.8] | 15.3 [12.4] | F = 0.33; 0.57 |
| Presurgical duration of mTLE, yr [SD] | 20.5 [12.9] | 26.2 [16.1] | F = 2.25; 0.13 |
| Febrile convulsions, cases | 14 (29.8%) | 15 (37.5%) | χ2 = 0.28; 0.59 |
| Meningitis, cases | 6 (12.8%) | 5 (12.5%) | χ2 = 0.001; 0.97 |
| Seizure frequency per month [SD] | 6.6 [10.7] | 8.1 [14.6] | F = 0.31; 0.58 |
| SGTCS, cases | 12 (25.5%) | 21 (52.5%) | χ2 = 5.58; 0.02a |
| Age at surgery, yr [SD] | 39.6 [12.5] | 39.9 [14.3] | F = 0.01; 0.91 |
| Side of surgery, L/R | 30/19 | 25/13 | χ2 = 0.05; 0.83 |
| Follow‐up, mo [SD] | 22.8 [8.2] | 23.7 [9.8] | F = 0.33; 0.72 |
a
Statistically significant.
F = female; ILAE = International League Against Epilepsy; L = left; M = male; MRI = magnetic resonance imaging; mTLE = mesial temporal lobe epilepsy; R = right; SD = standard deviation; SGTCS = secondary generalized tonic–clonic seizures.